(Q46416418)

22 December 2017

title

Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia (English)

1 reference

22 December 2017

0 references

Azra Raza

1

1 reference

22 December 2017

Murtaza Mehdi

2

1 reference

22 December 2017

Muhammad Mumtaz

3

1 reference

22 December 2017

Fahad Ali

4

1 reference

22 December 2017

Steven Lascher

5

1 reference

22 December 2017

Naomi Galili

6

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

22 December 2017

published in

Cancer

1 reference

22 December 2017

volume

113

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

1596-1604

1 reference

22 December 2017

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23789

7 January 2021

5-azacytidine in acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23789

7 January 2021

Drug insight: thalidomide as a treatment for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23789

7 January 2021

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23789

7 January 2021

An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23789

7 January 2021

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23789

7 January 2021

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23789

7 January 2021

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23789

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.23789

1 reference

7 January 2021

Comparative gene marker selection suite.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23789

7 January 2021

Response rate and survival after thalidomide-based therapy in 248 patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23789

7 January 2021

Identifiers

DOI

10.1002/CNCR.23789

1 reference

22 December 2017

PubMed ID

18720364

1 reference

22 December 2017